Radcliffe Capital Management’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-264,799
| Closed | -$31.6K | – | 500 |
|
|
2023
Q2 | $31.6K | Hold |
264,799
| – | – | ﹤0.01% | 281 |
|
|
2023
Q1 | $13K | Hold |
264,799
| – | – | ﹤0.01% | 497 |
|
|
2022
Q4 | $2.69M | Hold |
264,799
| – | – | 0.09% | 373 |
|
|
2022
Q3 | $2.61M | Buy |
264,799
+64,800
| +32% | +$638K | 0.06% | 515 |
|
|
2022
Q2 | $1.99M | Hold |
199,999
| – | – | 0.05% | 679 |
|
|
2022
Q1 | $1.98M | Hold |
199,999
| – | – | 0.05% | 668 |
|
|
2021
Q4 | $1.96M | Buy |
+199,999
| New | +$1.96M | 0.05% | 573 |
|